Health care workers' reactions to the newly introduced hepatitis B vaccine in Kalulushi, Zambia: Explained using the 5A taxonomy.
5A Taxonomy
Healthcare workers
Hepatitis B
Hesitancy
Vaccine
Journal
Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
29
06
2022
revised:
03
01
2023
accepted:
09
02
2023
entrez:
7
3
2023
pubmed:
8
3
2023
medline:
8
3
2023
Statut:
epublish
Résumé
Hepatitis B virus (HBV) is highly infectious and deadly disease that is transmitted through blood and body fluids. Health care workers (HCWs) have a high risk of contracting HBV in health care settings, the Hep-B vaccine one of the recommended prevention intervention/tools. However, uptake of the vaccine among HCWs remains low in Sub-Saharan Africa. We aimed to explore the barriers and facilitators to uptake of the vaccine offered free of charge to HCWs and nursing students in Kalulushi district, Copperbelt Province of Zambia. A total of 29 in-depth interviews (IDIs), either in person or via telephone, with participants before and after they received the vaccines were used to collect the data. We analysed the barriers and facilitators to full or partial vaccination using Penchasky and Thomas's (1981) 5A's (Access, Affordability, Awareness, Acceptance and Activation) taxonomy framework for vaccine hesitancy. All participants had access to the vaccine, and it was free of charge, making it affordable. Regarding awareness, all participants were aware of HBV infection as an occupational hazard, however, HCWs felt that more sensitization would be needed to increase awareness and knowledge of the vaccine. Acceptability of the vaccine was high among all completers and some non-completers as they felt it was safe and offered them protection. One non-completer felt coerced to accept the first dose due to supervisor expectations and would have preferred to have been given more time to decide. Most felt that vaccination should be compulsory for HCWs. Lastly, activation (vaccine uptake) among non-completers was hindered by late or no notification of appointments as the main reason for not completing the full vaccination schedule. HCWs advised that for countrywide roll-out, at least one weeks' notification would be necessary for HCWs to plan and be mentally prepared to be at their workstations when the vaccination is taking place. The need to offer the vaccine free of charge locally to ensure easy access and affordability is essential to increase vaccine uptake. Vaccination policies and guidelines for health workers, ongoing training and knowledge sharing are required. Involving trained champions in the facility can also help encourage HCWs to get vaccinated.
Identifiants
pubmed: 36880025
doi: 10.1016/j.jvacx.2023.100274
pii: S2590-1362(23)00015-3
pmc: PMC9985005
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100274Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Vaccines Vaccin. 2012 Jun 12;3(138):
pubmed: 24991482
BMC Infect Dis. 2018 Jun 28;18(1):288
pubmed: 29954344
BMC Med Educ. 2013 Nov 08;13:148
pubmed: 24200149
MMWR Morb Mortal Wkly Rep. 2002 Jun 28;51(25):549-52, 563
pubmed: 12118536
BMC Infect Dis. 2017 Dec 20;17(1):786
pubmed: 29262783
Ther Adv Vaccines Immunother. 2020 Jan 16;8:2515135519900743
pubmed: 32002499
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
Qual Health Res. 2017 Mar;27(4):591-608
pubmed: 27670770
Ann Occup Environ Med. 2017 Aug 10;29:32
pubmed: 29043086
BMC Public Health. 2016 Aug 03;15:706
pubmed: 27487845
Med J Armed Forces India. 2009 Jan;65(1):13-7
pubmed: 27408182
Biomed Res Int. 2018 Sep 25;2018:3673289
pubmed: 30356352
Can J Infect Control. 2009 Fall;24(3):159-64
pubmed: 19891169
Vaccine. 2016 Feb 17;34(8):1018-24
pubmed: 26672676
JMIR Mhealth Uhealth. 2017 Oct 04;5(10):e148
pubmed: 28978495
J Epidemiol Glob Health. 2016 Dec;6(4):229-241
pubmed: 27154428
Hepat Res Treat. 2011;2011:157089
pubmed: 22028961
Hepat Res Treat. 2017;2017:6470658
pubmed: 28751988
Vaccine. 2018 Aug 6;36(32 Pt B):4851-4860
pubmed: 29970299
Pan Afr Med J. 2019 Jun 10;33:96
pubmed: 31489074
J Hosp Infect. 2016 Oct;94(2):133-42
pubmed: 27546456
J Infect Public Health. 2012 Jun;5(3):244-9
pubmed: 22632598
Ann Afr Med. 2017 Apr-Jun;16(2):59-64
pubmed: 28469118